Infinity Announces the Date of Its Second Quarter 2012 Financial Results Conference Call and Webcast

Infinity Announces the Date of Its Second Quarter 2012 Financial Results Conference Call and Webcast

Kate Murray, 617-453-1179

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, August 7, 2012, at 8:30 a.m. ET. During the call, management will provide an update on Infinity's business and discuss the company's second quarter 2012 financial results.

A live webcast of the conference call can be accessed in the Investors/Media section of Infinity's website at . To participate in the conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526 (international) five minutes prior to start time. The conference ID number is 12570388. An archived version of the webcast will be available on Infinity's website for 30 days.

Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for diseases with significant unmet need. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs focused on the inhibition of heat shock protein 90, phosphoinositide-3-kinase and fatty acid amide hydrolase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company’s website at .

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.